InsiderTrades

Form 4 for COLL COLLEGIUM PHARMACEUTICAL, INC

Accepted 2024-05-28 00:00:00 ET · period of report 2024-05-23 · accession 0001062993-24-011338 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2024-05-28 2024-05-23+ COLL Dreyer Scott EVP, Chief Commercial Off S - Sale+OE $33.90 -108.0K 138.9K -44% -$3.66M
DM 2024-05-28 2024-05-23+ COLL Dreyer Scott EVP, Chief Commercial Off M - OptEx $24.03 +75.0K 190.1K +65% +$1.80M
DM 2024-05-28 2024-05-23+ COLL Dreyer Scott EVP, Chief Commercial Off M - OptEx $0.00 -75.0K 23.8K -76% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-05-24 S D 56,807 $33.98 105,902 D — — (F2) The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $33.68 to $34.25, inclusive.
2 Common Common Stock 2024-05-24 M A 23,791 $24.03 162,709 D — —
3 Common Common Stock 2024-05-23 S D 51,209 $33.82 138,918 D — — (F1) The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $33.36 to $34.19, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4.
4 Common Common Stock 2024-05-23 M A 51,209 $24.03 190,127 D — —
5 Derivative Stock Option (Right to Purchase) 2024-05-24 M D 23,791 $0.00 0 D $24.03 · — to 2028-04-04 23,791 Common Stock (F3) The option is fully vested and exercisable.
6 Derivative Stock Option (Right to Purchase) 2024-05-23 M D 51,209 $0.00 23,791 D $24.03 · — to 2028-04-04 51,209 Common Stock (F3) The option is fully vested and exercisable.